lenvatinib and Graves-Ophthalmopathy

lenvatinib has been researched along with Graves-Ophthalmopathy* in 1 studies

Other Studies

1 other study(ies) available for lenvatinib and Graves-Ophthalmopathy

Article	Year
Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular Thyroid Cancer, Graves' Disease, and Graves' Ophthalmopathy. Thyroid : official journal of the American Thyroid Association, 2021, Volume: 31, Issue:10 Topics: Adenocarcinoma, Follicular; Antibodies, Monoclonal; Antineoplastic Agents; Autoantibodies; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; Iodine Radioisotopes; Middle Aged; Phenylurea Compounds; Quinolines; Radiopharmaceuticals; Receptors, Thyrotropin; Thyroid Neoplasms; Treatment Outcome	2021

Article

Year

Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular Thyroid Cancer, Graves' Disease, and Graves' Ophthalmopathy.

Thyroid : official journal of the American Thyroid Association, 2021, Volume: 31, Issue:10

Topics: Adenocarcinoma, Follicular; Antibodies, Monoclonal; Antineoplastic Agents; Autoantibodies; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; Iodine Radioisotopes; Middle Aged; Phenylurea Compounds; Quinolines; Radiopharmaceuticals; Receptors, Thyrotropin; Thyroid Neoplasms; Treatment Outcome

2021